RT Journal Article
T1 Thoracic imaging of coronavirus disease 2019 (COVID-19) in children: a series of 91 cases.
A1 Caro-Dominguez, Pablo
A1 Shelmerdine, Susan Cheng
A1 Toso, Seema
A1 Secinaro, Aurelio
A1 Toma, Paolo
A1 Damasio, Maria Beatrice
A1 Navallas, María
A1 Riaza-Martin, Lucia
A1 Gomez-Pastrana, David
A1 Ghadimi Mahani, Maryam
A1 Desoky, Sarah M
A1 Ugas Charcape, Carlos F
A1 Almanza-Aranda, Judith
A1 Ucar, Maria Elena
A1 Lovrenski, Jovan
A1 Gorkem, Sureyya Burcu
A1 Alexopoulou, Efthymia
A1 Ciet, Pierluigi
A1 van Schuppen, Joost
A1 Ducou le Pointe, Hubert
A1 Goo, Hyun Woo
A1 Kellenberger, Christian J
A1 Raissaki, Maria
A1 Owens, Catherine M
A1 Hirsch, Franz Wolfgang
A1 van Rijn, Rick R
A1 Collaborators of the European Society of Paediatric Radiology Cardiothoracic Task Force, 
K1 COVID-19
K1 Children
K1 Computed tomography
K1 Coronavirus
K1 Imaging
K1 Lower respiratory tract infection
K1 Pneumonitis
K1 Radiography
AB Pulmonary infection with SARS-CoV-2 virus (severe acute respiratory syndrome coronavirus 2; COVID-19) has rapidly spread worldwide to become a global pandemic. To collect paediatric COVID-19 cases worldwide and to summarize both clinical and imaging findings in children who tested positive on polymerase chain reaction testing for SARS-CoV-2. Data were collected by completion of a standardised case report form submitted to the office of the European Society of Paediatric Radiology from March 12 to April 8, 2020. Chest imaging findings in children younger than 18 years old who tested positive on polymerase chain reaction testing for SARS-CoV-2 were included. Representative imaging studies were evaluated by multiple senior paediatric radiologists from this group with expertise in paediatric chest imaging. Ninety-one children were included (49 males; median age: 6.1 years, interquartile range: 1.0 to 13.0 years, range: 9 days-17 years). Most had mild symptoms, mostly fever and cough, and one-third had coexisting medical conditions. Eleven percent of children presented with severe symptoms and required intensive unit care. Chest radiographs were available in 89% of patients and 10% of them were normal. Abnormal chest radiographs showed mainly perihilar bronchial wall thickening (58%) and/or airspace consolidation (35%). Computed tomography (CT) scans were available in 26% of cases, with the most common abnormality being ground glass opacities (88%) and/or airspace consolidation (58%). Tree in bud opacities were seen in 6 of 24 CTs (25%). Lung ultrasound and chest magnetic resonance imaging were rarely utilized. It seems unnecessary to perform chest imaging in children to diagnose COVID-19. Chest radiography can be used in symptomatic children to assess airway infection or pneumonia. CT should be reserved for when there is clinical concern to assess for possible complications, especially in children with coexisting medical conditions.
YR 2020
FD 2020-08-04
LK http://hdl.handle.net/10668/16044
UL http://hdl.handle.net/10668/16044
LA en
DS RISalud
RD Apr 11, 2025